Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1948;7(3):143–151.

Bal in the Treatment of Gold Toxicity

J G Macleod 1
PMCID: PMC1030591  PMID: 18623786

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freyberg R. H., Block W. D., Levey S. METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE. J Clin Invest. 1941 Jul;20(4):401–412. doi: 10.1172/JCI101235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Long W. K., Farah A. Effect of Some Sulfhydryl-containing Substances on the Toxicity of an Organic Mercurial Compound. Science. 1946 Sep 6;104(2697):220–221. doi: 10.1126/science.104.2697.220. [DOI] [PubMed] [Google Scholar]
  3. Longcope W. T., Luetscher J. A., Calkins E., Grob D., Bush S. W., Eisenberg H. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL. J Clin Invest. 1946 Jul;25(4):557–567. doi: 10.1172/JCI101738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Longcope W. T., Luetscher J. A., Wintrobe M. M., Jäger V. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL. J Clin Invest. 1946 Jul;25(4):528–533. doi: 10.1172/JCI101734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Modell W., Gold H., Cattell M. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN. J Clin Invest. 1946 Jul;25(4):480–487. doi: 10.1172/JCI101731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. SIMPSON N. R. W. Treatment of gold dermatitis by BAL. Br Med J. 1948 Mar 20;1(4550):545–545. doi: 10.1136/bmj.1.4550.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SLOT G., McDONALD A. D. The use and value of BAL in gold dermatitis. Br Med J. 1947 Nov 15;2(4532):773–773. doi: 10.1136/bmj.2.4532.773-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sulzberger M. B., Baer R. L., Kanof A. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION. J Clin Invest. 1946 Jul;25(4):474–479. doi: 10.1172/JCI101730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Waters L. L., Stock C. BAL (BRITISH ANTI-LEWISITE). Science. 1945 Dec 14;102(2659):601–606. doi: 10.1126/science.102.2659.601. [DOI] [PubMed] [Google Scholar]
  10. Wexler J., Eagle H., Tatum H. J., Magnuson H. J., Watson E. B. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE. J Clin Invest. 1946 Jul;25(4):467–473. doi: 10.1172/JCI101729. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES